Son Hwa-Young, Nishikawa Akiyoshi, Okazaki Kazushi, Kitamura Yasuki, Kanki Keita, Lee Kyong-Youl, Umemura Takashi, Hirose Masao
Division of Pathology, National Institute of Health Sciences, Setagaya-ku, Tokyo 158-8501, Japan.
Toxicol Pathol. 2004 May-Jun;32(3):338-44. doi: 10.1080/01926230490431853.
The specificity of copromotion effects of caffeine with known goitrogenic factors on thyroid carcinogenesis was examined in rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN). Male F344 rats were divided into 8 groups, each consisting of 10 animals, and received a single sc injection of 2,800 mg/kg DHPN. From one week after the DHPN initiation, they were given basal diet, iodine deficiency (ID) diet, 500 ppm phenobarbital (PB) solution or 1,000 ppm sulfadimethoxine (SDM) solution with or without 1,500 ppm caffeine feeding for 12 weeks. The caffeine, PB, SDM, and ID treatments significantly (p < 0.05 or 0.01) increased the relative thyroid weights, and the increases with PB or ID were further (p < 0.05 or 0.01) enhanced in combination with caffeine. SDM drastically promoted thyroid carcinogenesis in association with increased serum TSH levels regardless of the caffeine treatment. Thyroid follicular carcinomas and adenomas were more frequently observed in the additional caffeine groups than in the ID alone groups. The incidence and multiplicity of focal thyroid follicular hyperplasias in the ID-treated groups were significantly (p < 0.05 and 0.01) elevated in the case of combination with caffeine. Increases in serum TSH levels with PB or ID were also further enhanced in combination with caffeine. Serum thyroid hormone levels were significantly (p < 0.01) decreased by SDM but significantly (p < 0.05 or 0.01) increased by caffeine, PB or ID. Our results clearly indicate that dietary caffeine at a high dose of 1,500 ppm interacts with ID, but neither SDM nor PB, to promote rat thyroid carcinogenesis although the combined caffeine + PB treatment somewhat affected thyroid weights as well as thyroid hormone levels.
在经N-双(2-羟丙基)亚硝胺(DHPN)预处理的大鼠中,研究了咖啡因与已知致甲状腺肿因子对甲状腺癌发生的协同促进作用的特异性。雄性F344大鼠分为8组,每组10只,单次皮下注射2800mg/kg DHPN。从DHPN注射开始一周后,给它们喂食基础饲料、缺碘(ID)饲料、500ppm苯巴比妥(PB)溶液或1000ppm磺胺二甲氧嘧啶(SDM)溶液,同时或不同时添加1500ppm咖啡因,持续12周。咖啡因、PB、SDM和ID处理均显著(p<0.05或0.01)增加了甲状腺相对重量,PB或ID与咖啡因联合使用时增加更为显著(p<0.05或0.01)。无论咖啡因处理如何,SDM均与血清促甲状腺激素(TSH)水平升高相关,显著促进甲状腺癌发生。与单独ID组相比,额外添加咖啡因的组中甲状腺滤泡癌和腺瘤更为常见。ID处理组中,与咖啡因联合使用时,局灶性甲状腺滤泡增生的发生率和多发性显著(p<0.05和0.01)升高。PB或ID联合咖啡因时,血清TSH水平的升高也进一步增强。SDM显著(p<0.01)降低血清甲状腺激素水平,而咖啡因、PB或ID则显著(p<0.05或0.01)升高血清甲状腺激素水平。我们的结果清楚地表明,1500ppm高剂量的膳食咖啡因与ID相互作用,但不与SDM或PB相互作用,以促进大鼠甲状腺癌发生,尽管咖啡因+PB联合处理在一定程度上影响了甲状腺重量和甲状腺激素水平。